156 related articles for article (PubMed ID: 33301750)
1. Well-differentiated neuroendocrine tumors of the lower urinary tract: biologic behavior of a rare entity.
Rodriguez Pena MDC; Salles DC; Epstein JI; Canete-Portillo S; Tregnago AC; Ramirez J; Meliti A; Netto GJ
Hum Pathol; 2021 Mar; 109():53-58. PubMed ID: 33301750
[TBL] [Abstract][Full Text] [Related]
2. Primary carcinoid tumors of the urinary bladder and prostatic urethra: a clinicopathologic study of 6 cases.
Chen YB; Epstein JI
Am J Surg Pathol; 2011 Mar; 35(3):442-6. PubMed ID: 21317716
[TBL] [Abstract][Full Text] [Related]
3. Well-differentiated neuroendocrine tumor of the urinary bladder expressing GATA 3.
Marletta S; Martignoni G; Ghimenton C; Stefanizzi L; Marcolini L; Caliò A
Virchows Arch; 2023 Apr; 482(4):783-788. PubMed ID: 36543974
[TBL] [Abstract][Full Text] [Related]
4. Inverted papilloma of the bladder: a review and an analysis of the recent literature of 365 patients.
Picozzi S; Casellato S; Bozzini G; Ratti D; Macchi A; Rubino B; Pace G; Carmignani L
Urol Oncol; 2013 Nov; 31(8):1584-90. PubMed ID: 22520573
[TBL] [Abstract][Full Text] [Related]
5. Florid von Brunn nests mimicking urothelial carcinoma: a morphologic and immunohistochemical comparison to the nested variant of urothelial carcinoma.
Volmar KE; Chan TY; De Marzo AM; Epstein JI
Am J Surg Pathol; 2003 Sep; 27(9):1243-52. PubMed ID: 12960809
[TBL] [Abstract][Full Text] [Related]
6. A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas.
Tang LH; Basturk O; Sue JJ; Klimstra DS
Am J Surg Pathol; 2016 Sep; 40(9):1192-202. PubMed ID: 27259015
[TBL] [Abstract][Full Text] [Related]
7. [Urothelial hyperplastic lesion with endophytic growth pattern: a clinicopathologic study].
Xiao L; Wang CF; Zhu XZ; Yin YL; Chen Y; Lu C; Yu B
Zhonghua Bing Li Xue Za Zhi; 2011 May; 40(5):319-23. PubMed ID: 21756826
[TBL] [Abstract][Full Text] [Related]
8. Paraganglioma of the urinary bladder: a clinicopathologic spectrum of a series of 14 cases emphasizing diagnostic dilemmas.
Menon S; Goyal P; Suryawanshi P; Tongaonkar H; Joshi A; Bakshi G; Desai S
Indian J Pathol Microbiol; 2014; 57(1):19-23. PubMed ID: 24739826
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical study of neuroendocrine differentiation in primary glandular lesions and tumors of the urinary bladder.
Bollito ER; Pacchioni D; Lopez-Beltran A; Volante M; Terrone C; Casetta G; Mari M; DePompa R; Cappia S; Papotti M
Anal Quant Cytol Histol; 2005 Aug; 27(4):218-24. PubMed ID: 16220833
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptors in the human male bladder, prostatic urethra, and prostate. An immunohistochemical and biochemical study.
Bødker A; Balslev E; Juul BR; Stimpel H; Meyhoff HH; Hedlund H; Hedlund P; Iversen HG; Andersson KE
Scand J Urol Nephrol; 1995 Jun; 29(2):161-5. PubMed ID: 7569793
[TBL] [Abstract][Full Text] [Related]
11. Updates on Urinary Bladder Tumors With Neuroendocrine Features.
Akbulut D; Al-Ahmadie H
Adv Anat Pathol; 2024 May; 31(3):169-177. PubMed ID: 38523484
[TBL] [Abstract][Full Text] [Related]
12. Urachal carcinomas of the nonglandular type: salient features and considerations in pathologic diagnosis.
Paner GP; Barkan GA; Mehta V; Sirintrapun SJ; Tsuzuki T; Sebo TJ; Jimenez RE
Am J Surg Pathol; 2012 Mar; 36(3):432-42. PubMed ID: 22301493
[TBL] [Abstract][Full Text] [Related]
13. Neuroendocrine carcinoma of the urinary bladder. 15-year retrospective analysis.
Perán Teruel M; Giménez Bachs JM; Martínez Ruiz J; Fernández Anguita PJ; Nuñez Sarrión MA; Pastor Guzmán JM; Salinas Sánchez AS; Lorenzo Romero JG; Donate Moreno MJ; Atienzar Tobarra M; Virseda Rodríguez JA
Arch Esp Urol; 2012 Mar; 65(2):237-43. PubMed ID: 22414452
[TBL] [Abstract][Full Text] [Related]
14. Detection of residual tumor cells in bladder biopsy specimens: pitfalls in the interpretation of cytokeratin stains.
Tamas EF; Epstein JI
Am J Surg Pathol; 2007 Mar; 31(3):390-7. PubMed ID: 17325480
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical analysis of the proliferative activity of neuroendocrine tumors from various organs. Are there indications for a neuroendocrine tumor-carcinoma sequence?
Helpap B; Köllermann J
Virchows Arch; 2001 Jan; 438(1):86-91. PubMed ID: 11213840
[TBL] [Abstract][Full Text] [Related]
16. Well-Differentiated Neuroendocrine Tumors with a Morphologically Apparent High-Grade Component: A Pathway Distinct from Poorly Differentiated Neuroendocrine Carcinomas.
Tang LH; Untch BR; Reidy DL; O'Reilly E; Dhall D; Jih L; Basturk O; Allen PJ; Klimstra DS
Clin Cancer Res; 2016 Feb; 22(4):1011-7. PubMed ID: 26482044
[TBL] [Abstract][Full Text] [Related]
17. Nested variant of urothelial carcinoma: a clinicopathologic and immunohistochemical study of 30 pure and mixed cases.
Wasco MJ; Daignault S; Bradley D; Shah RB
Hum Pathol; 2010 Feb; 41(2):163-71. PubMed ID: 19800100
[TBL] [Abstract][Full Text] [Related]
18. Morphology and therapeutic strategies for neuroendocrine tumors of the genitourinary tract.
Helpap B
Cancer; 2002 Oct; 95(7):1415-20. PubMed ID: 12237909
[TBL] [Abstract][Full Text] [Related]
19. Superficial transitional cell carcinoma of the ureteral orifice: higher risk of developing subsequent upper urinary tract tumors.
Chou EC; Lin AT; Chen KK; Chang LS
Int J Urol; 2006 Jun; 13(6):682-5. PubMed ID: 16834642
[TBL] [Abstract][Full Text] [Related]
20. Paraganglioma of the urinary bladder: a lesion that may be misdiagnosed as urothelial carcinoma in transurethral resection specimens.
Zhou M; Epstein JI; Young RH
Am J Surg Pathol; 2004 Jan; 28(1):94-100. PubMed ID: 14707870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
